Activators for oligonucleotide synthesis
First Claim
1. A method for the preparation of a compound of formula:
-
wherein;
R1 is a nucleoside or an oligonucleotide;
R2 is a nucleoside linked to a solid support, or an oligonucleotide linked to a solid support;
Pg is a phosphorus protecting group;
comprising;
providing a phosphoramidite of formula;
wherein R6 is —
N(R7)2 wherein R7 is alkyl having from one to about six carbons;
or R7 is a heterocycloalkyl or heterocycloalkenyl ring containing from 4 to 7 atoms, and having up to 3 heteroatoms selected from nitrogen, sulfur, and oxygen; and
reacting said phosphoramidite with a hydroxyl group of a nucleoside linked to a solid support, or an oligonucleotide linked to a solid support;
said reaction being performed in the presence of an activating reagent, said activating reagent comprising at least one pyridinium salt and at least one substituted imidazole.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates to improved methods for the preparation of nucleoside phosphoramidites and oligonucleotides. In one aspect, the methods of the invention are used to prepare phosphitylating reagents using pyridinium salts as activators. In a further aspect, the methods of the invention are used to prepare internucleoside linkages using activators which include at least one pyridinium salt and at least one substituted imidazole. In a further aspect, methods are provided preparation of internucleoside linkages between nucleosides having 2′-substituents using imidazolium or benzimidazolium salts as an activator. In a further aspect, methods are provided preparation of internucleoside linkages between nucleosides having bioreversible protecting group that confers enhanced chemical and biophysical properties, without exocyclic amine protection, using imidazolium or benzimidazolium salts as an activator.
-
Citations
6 Claims
-
1. A method for the preparation of a compound of formula:
-
wherein; R1 is a nucleoside or an oligonucleotide;
R2 is a nucleoside linked to a solid support, or an oligonucleotide linked to a solid support;
Pg is a phosphorus protecting group;
comprising;
providing a phosphoramidite of formula;
whereinR6 is —
N(R7)2 wherein R7 is alkyl having from one to about six carbons;
or R7 is a heterocycloalkyl or heterocycloalkenyl ring containing from 4 to 7 atoms, and having up to 3 heteroatoms selected from nitrogen, sulfur, and oxygen; and
reacting said phosphoramidite with a hydroxyl group of a nucleoside linked to a solid support, or an oligonucleotide linked to a solid support;
said reaction being performed in the presence of an activating reagent, said activating reagent comprising at least one pyridinium salt and at least one substituted imidazole. - View Dependent Claims (2, 3, 4, 5, 6)
where X−
O-mesyl, −
O-tosyl, −
Br, −
O-trifluorosulfonyl, hexafluorophosphate or tetrafluoroborate.
-
-
3. The method of claim 2 wherein the substituted imidazole is 1-methylimidazole.
-
4. The method of claim 2 wherein X is trifluoroacetate.
-
5. The method of claim 1 wherein the phosphoramidite is reacted with the 5′
- -hydroxyl of a solid-support bound nucleoside or oligonucleotide.
-
6. The method of claim 1 wherein the oligonucleotide comprises phosphorothioate intersugar linkages.
Specification
-
- Resources
-
Current AssigneeISIS Pharmaceuticals Incorporated (Ionis Pharmaceuticals, Inc.)
-
Original AssigneeISIS Pharmaceuticals Incorporated (Ionis Pharmaceuticals, Inc.)
-
InventorsManoharan, Muthia, Ravikumar, Vasulinga T.
-
Primary Examiner(s)Lewis, Patrick T
-
Application NumberUS09/708,224Time in Patent Office1,539 DaysField of Search536/25.3, 536/25.34, 536/25.6US Class Current536/25.34CPC Class CodesC07H 21/00 Compounds containing two or...Y02P 20/55 Design of synthesis routes,...
